PLCL1 Rs7595412 Variation is Not Associated with Hip Bone Size Variation in Postmenopausal Danish Women

Overview

Journal BMC Med Genet

Publisher Biomed Central

Specialty Genetics

Date 2009 Dec 25

PMID 20030815

Authors

Stephane Cauchi

Inger Byrjalsen

Emmanuelle Durand

Morten A Karsdal

Philippe Froguel

Affiliations

Soon will be listed here.

Abstract

Background: Bone size (BS) variation is under strong genetic control and plays an important role in determining bone strength and fracture risk. Recently, a genome-wide association study identified polymorphisms associated with hip BS variation in the PLCL1 (phospholipase c-like 1) locus. Carriers of the major A allele of the most significant polymorphism, rs7595412, have around 17% larger hip BS than non-carriers. We therefore hypothesized that this polymorphism may also influence postmenopausal complications.

Methods: The effects of rs7595412 on hip BS, bone mineral density (BMD), vertebral fractures, serum Crosslaps and osteocalcin levels were analyzed in 1,191 postmenopausal Danish women.

Results: This polymorphism had no influence on hip and spine BS as well as on femur and spine BMD. Women carrying at least one copy of the A allele had lower levels of serum osteocalcin as compared with those homozygous for the G allele (p = 0.03) whereas no effect on serum Crosslaps was detected. Furthermore, women homozygous for the A allele were more affected by vertebral fractures than those carrying at least one copy of the G allele (p = 0.04).

Conclusions: In postmenopausal women, our results suggest that the PLCL1 rs7595412 polymorphism has no obvious effect on hip BS or BMD but may be nominally associated with increased proportion of vertebral fracture and increased levels of osteocalcin.

References

Lei S, Deng F, Xiao S, Chen X, Deng H . Association and haplotype analyses of the COL1A2 and ER-alpha gene polymorphisms with bone size and height in Chinese. Bone. 2005; 36(3):533-41. DOI: 10.1016/j.bone.2004.11.002. View

Valimaki M, Tahtela R, Jones J, Peterson J, Riggs B . Bone resorption in healthy and osteoporotic postmenopausal women: comparison markers for serum carboxy-terminal telopeptide of type I collagen and urinary pyridinium cross-links. Eur J Endocrinol. 1994; 131(3):258-62. DOI: 10.1530/eje.0.1310258. View

Karasik D, Ginsburg E, Livshits G, Pavlovsky O, Kobyliansky E . Evidence of major gene control of cortical bone loss in humans. Genet Epidemiol. 2000; 19(4):410-21. DOI: 10.1002/1098-2272(200012)19:4<410::AID-GEPI11>3.0.CO;2-K. View

Liu Y, Wilson S, Wang L, Liu X, Guo Y, Li J . Identification of PLCL1 gene for hip bone size variation in females in a genome-wide association study. PLoS One. 2008; 3(9):e3160. PMC: 2522269. DOI: 10.1371/journal.pone.0003160. View

Cohen Z, Kalichman L, Kobyliansky E, Malkin I, Almog E, Livshits G . Cortical index and size of hand bones: segregation analysis and linkage with the 11q12-13 segment. Med Sci Monit. 2003; 9(3):MT13-20. View

Alonso C, Curiel M, Carranza F, Cano R, Perez A . Femoral bone mineral density, neck-shaft angle and mean femoral neck width as predictors of hip fracture in men and women. Multicenter Project for Research in Osteoporosis. Osteoporos Int. 2000; 11(8):714-20. View

Deng H, Xu F, Liu Y, Shen H, Deng H, Huang Q . A whole-genome linkage scan suggests several genomic regions potentially containing QTLs underlying the variation of stature. Am J Med Genet. 2002; 113(1):29-39. DOI: 10.1002/ajmg.10742. View

Yang T, Chen X, Guo Y, Lei S, Wang J, Zhou Q . Genome-wide copy-number-variation study identified a susceptibility gene, UGT2B17, for osteoporosis. Am J Hum Genet. 2008; 83(6):663-74. PMC: 2667994. DOI: 10.1016/j.ajhg.2008.10.006. View

Liu P, Qin Y, Recker R, Deng H . Evidence for a major gene underlying bone size variation in the Chinese. Am J Hum Biol. 2003; 16(1):68-77. DOI: 10.1002/ajhb.10240. View

10.

Riddle R, Taylor A, Genetos D, Donahue H . MAP kinase and calcium signaling mediate fluid flow-induced human mesenchymal stem cell proliferation. Am J Physiol Cell Physiol. 2005; 290(3):C776-84. DOI: 10.1152/ajpcell.00082.2005. View

11.

Fairbrother U, Tanko L, Walley A, Christiansen C, Froguel P, Blakemore A . Leptin receptor genotype at Gln223Arg is associated with body composition, BMD, and vertebral fracture in postmenopausal Danish women. J Bone Miner Res. 2007; 22(4):544-50. DOI: 10.1359/jbmr.070114. View

12.

Ahlborg H, Johnell O, Turner C, Rannevik G, Karlsson M . Bone loss and bone size after menopause. N Engl J Med. 2003; 349(4):327-34. DOI: 10.1056/NEJMoa022464. View

13.

Deng H, Deng X, Conway T, Xu F, Heaney R, Recker R . Determination of bone size of hip, spine, and wrist in human pedigrees by genetic and lifestyle factors. J Clin Densitom. 2002; 5(1):45-56. DOI: 10.1385/jcd:5:1:045. View

14.

Einhorn T, Wakley G, Linkhart S, Rush E, Maloney S, FAIERMAN E . Incorporation of sodium fluoride into cortical bone does not impair the mechanical properties of the appendicular skeleton in rats. Calcif Tissue Int. 1992; 51(2):127-31. DOI: 10.1007/BF00298500. View

15.

Zmuda J, Cauley J, Kuller L, Ferrell R . A common promotor variant in the cytochrome P450c17alpha (CYP17) gene is associated with bioavailability testosterone levels and bone size in men. J Bone Miner Res. 2001; 16(5):911-7. DOI: 10.1359/jbmr.2001.16.5.911. View

16.

Duan Y, Tabensky A, DeLuca V, Seeman E . The benefit of hormone replacement therapy on bone mass is greater at the vertebral body than posterior processes or proximal femur. Bone. 1997; 21(5):447-51. DOI: 10.1016/s8756-3282(97)00177-4. View

17.

Hodsman A, Drost D . The response of vertebral bone mineral density during the treatment of osteoporosis with sodium fluoride. J Clin Endocrinol Metab. 1989; 69(5):932-8. DOI: 10.1210/jcem-69-5-932. View

18.

Cranney A, Jamal S, Tsang J, Josse R, Leslie W . Low bone mineral density and fracture burden in postmenopausal women. CMAJ. 2007; 177(6):575-80. PMC: 1963365. DOI: 10.1503/cmaj.070234. View

19.

Fang Y, van Meurs J, Rivadeneira F, van Schoor N, van Leeuwen J, Lips P . Vitamin D receptor gene haplotype is associated with body height and bone size. J Clin Endocrinol Metab. 2007; 92(4):1491-501. DOI: 10.1210/jc.2006-1134. View

20.

Chavassieux P, Chenu C, Valentin-Opran A, Delmas P, Boivin G, CHAPUY M . In vitro exposure to sodium fluoride does not modify activity or proliferation of human osteoblastic cells in primary cultures. J Bone Miner Res. 1993; 8(1):37-44. DOI: 10.1002/jbmr.5650080106. View